These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 7505252)

  • 41. Phosphatidylinositol-3-kinase is a non-tyrosine phosphorylated member of the insulin receptor signalling complex.
    Sung CK; Goldfine ID
    Biochem Biophys Res Commun; 1992 Dec; 189(2):1024-30. PubMed ID: 1281985
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sphingomyelinase and ceramide suppress insulin-induced tyrosine phosphorylation of the insulin receptor substrate-1.
    Kanety H; Hemi R; Papa MZ; Karasik A
    J Biol Chem; 1996 Apr; 271(17):9895-7. PubMed ID: 8626623
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alterations in insulin receptor and substrate phosphorylation in hypertensive rats.
    Kahn CR; Saad MJ
    J Am Soc Nephrol; 1992 Oct; 3(4 Suppl):S69-77. PubMed ID: 1457763
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization of a 60-kilodalton substrate of the insulin receptor kinase.
    Hosomi Y; Shii K; Ogawa W; Matsuba H; Yoshida M; Okada Y; Yokono K; Kasuga M; Baba S; Roth RA
    J Biol Chem; 1994 Apr; 269(15):11498-502. PubMed ID: 7512567
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The insulin receptor and its substrate: molecular determinants of early events in insulin action.
    Kahn CR; White MF; Shoelson SE; Backer JM; Araki E; Cheatham B; Csermely P; Folli F; Goldstein BJ; Huertas P
    Recent Prog Horm Res; 1993; 48():291-339. PubMed ID: 7680139
    [No Abstract]   [Full Text] [Related]  

  • 46. Insulin stimulates tyrosine phosphorylation of the insulin receptor in a cell-free system.
    Kasuga M; Zick Y; Blithe DL; Crettaz M; Kahn CR
    Nature; 1982 Aug; 298(5875):667-9. PubMed ID: 6178977
    [No Abstract]   [Full Text] [Related]  

  • 47. After insulin binds.
    Rosen OM
    Science; 1987 Sep; 237(4821):1452-8. PubMed ID: 2442814
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular determinants of insulin action.
    Kahn CR; Goldfine AB
    J Diabetes Complications; 1993; 7(2):92-105. PubMed ID: 8518461
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prostaglandylinositol cyclic phosphate (cPIP): a novel second messenger of insulin action. Comparative analysis of two kinds of "insulin mediators".
    Shashkin PN; Wasner HK; Ortmeyer HK; Hansen BC
    Diabetes Metab Res Rev; 2001; 17(4):273-84. PubMed ID: 11544611
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Some thoughts on the mechanism of action of insulin.
    Exton JH
    Diabetes; 1991 May; 40(5):521-6. PubMed ID: 1902425
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of mutant insulin receptors in structure-function studies of insulins.
    Schäffer L; Markussen J; Kjeldsen T; Andersen AS; Wiberg FC; Tager H
    Biochem Soc Trans; 1992 Nov; 20(4):842-3. PubMed ID: 1487077
    [No Abstract]   [Full Text] [Related]  

  • 52. Mutational analysis of insulin receptor function: consensus and controversy.
    Tavaré JM; Siddle K
    Biochim Biophys Acta; 1993 Jul; 1178(1):21-39. PubMed ID: 8329456
    [No Abstract]   [Full Text] [Related]  

  • 53. Vitamin D, sub-inflammation and insulin resistance. A window on a potential role for the interaction between bone and glucose metabolism.
    Garbossa SG; Folli F
    Rev Endocr Metab Disord; 2017 Jun; 18(2):243-258. PubMed ID: 28409320
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Gly(972)Arg variant of human IRS1 gene is associated with variation in glomerular filtration rate likely through impaired insulin receptor signaling.
    Thameem F; Puppala S; Schneider J; Bhandari B; Arya R; Arar NH; Vasylyeva TL; Farook VS; Fowler S; Almasy L; Blangero J; Duggirala R; Abboud HE
    Diabetes; 2012 Sep; 61(9):2385-93. PubMed ID: 22617042
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interplay between insulin resistance and estrogen deficiency as co- activators in carcinogenesis.
    Suba Z
    Pathol Oncol Res; 2012 Apr; 18(2):123-33. PubMed ID: 21984197
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hyperinsulinemia is associated with altered insulin receptor mRNA splicing in muscle of the spontaneously obese diabetic rhesus monkey.
    Huang Z; Bodkin NL; Ortmeyer HK; Hansen BC; Shuldiner AR
    J Clin Invest; 1994 Sep; 94(3):1289-96. PubMed ID: 8083370
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular determinants of insulin action.
    Kahn CR; Folli F
    Horm Res; 1993; 39 Suppl 3():93-101. PubMed ID: 7505252
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Modulation of insulin receptor, insulin receptor substrate-1, and phosphatidylinositol 3-kinase in liver and muscle of dexamethasone-treated rats.
    Saad MJ; Folli F; Kahn JA; Kahn CR
    J Clin Invest; 1993 Oct; 92(4):2065-72. PubMed ID: 7691892
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Regulation of insulin receptor, insulin receptor substrate-1 and phosphatidylinositol 3-kinase in 3T3-F442A adipocytes. Effects of differentiation, insulin, and dexamethasone.
    Saad MJ; Folli F; Araki E; Hashimoto N; Csermely P; Kahn CR
    Mol Endocrinol; 1994 May; 8(5):545-57. PubMed ID: 7520127
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Insulin stimulation of phosphatidylinositol 3-kinase activity and association with insulin receptor substrate 1 in liver and muscle of the intact rat.
    Folli F; Saad MJ; Backer JM; Kahn CR
    J Biol Chem; 1992 Nov; 267(31):22171-7. PubMed ID: 1385396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.